Previous reports have documented the co-occurrence of extra-adrenal tumors, such as breast cancer, parathyroid tumors, thyroid cancer, and thyroid adenomas, in individuals with ARMC5 variants [4]. This evidence concerns the gene ARMC5 and Thyroid adenoma.